Scalper1 News
Medical-device maker ResMed (RMD) vaulted to a new high Friday after its fiscal Q2 results beat estimates late Thursday. For the quarter ended Dec. 31, ResMed earning 65 cents a share, up 6.6% from the year-earlier quarter and beating estimates by 4 cents. Sales rose 10% to $423 million, topping consensus by $19 million and the second straight quarter of acceleration. The company’s growth had been slowing the last few years due to pricing Scalper1 News
Scalper1 News